Xiancheng Chen

Dr. Xiancheng Chen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
YXYali Xu
Yali Xu
JDJianfeng Duan
Jianfeng Duan
DWDacheng Wang
Dacheng Wang
JLJiali Liu
Jiali Liu
XCXiancheng Chen
Xiancheng Chen
WYWenkui Yu
Wenkui Yu
Many patients in intensive care units, especially the elderly, suffer from chronic critical illness and exhibit a new pathophysiological phenotype: persistent inflammation, immunosuppression, and catabolism syndrome (PICS). Most patients with PICS have a constellation of digestive-system symptoms and gut failure. Akkermansia muciniphila (Akk) is a commensal gut bacterium that reduces inflammation, balances immune responses, modulates energy metabolism, and supports gut health. This study investigated the protective effects and underlying mechanisms of live and pasteurized Akk in treating PICS in a mouse model. PICS was induced on day 14 after performing cecal ligation and puncture (CLP) on day 1 and administrating lipopolysaccharide on day 11. Pasteurized or live Akk, or phosphate-buffered saline was administered twice daily by oral gavage for 7 days. Both live and pasteurized Akk attenuated PICS, as evidenced by reduced weight loss, and a reduction in symptoms and serum cytokine/chemokine levels. Liver and intestinal injuries were mitigated, and intestinal barrier integrity improved with Akk administration. Analysis of 16S rRNA amplicon sequences showed that Akk induced significant intestinal microbiota alterations, including increased abundance of Akk, Muribaculaceae, Parabacterbides goldsteinii, and decreased abundance of Escherichia_Shigella and Enterobacteriaceae. Collectively, Akk alleviates PICS by enhancing gut barrier function and reshaped the microbial community.

28 September 2026 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
AWAsly Chua An Wen
Asly Chua An Wen
XCXiancheng Chen
Xiancheng Chen
WZWenli Zhang
Wenli Zhang

18 February 2026 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
JLJiaqi Li
Jiaqi Li
YXYuanbo Xue
Yuanbo Xue
JCJunjie Cui
Junjie Cui
MCMing Chen
Ming Chen
YYYong You
Yong You
WYWenkui Yu
Wenkui Yu

16 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Xuetao ZhangXuetao Zhang
Xuetao Zhang
MCMING CHEN
MING CHEN
BZBeiyuan Zhang
Beiyuan Zhang
TGTao Gao
Tao Gao
YXYing Xu
Ying Xu
WYWenkui Yu
Wenkui Yu
Background: Patients with severe acute pancreatitis (SAP) are at high risk for developing chronic critical illness (CCI) and persistent inflammation, immunosuppression, and catabolism syndrome (PICS). However, the specific risk factors and prognostic implications of these conditions remain unclear. Methods: This single-center retrospective cohort study enrolled adult patients with SAP requiring ICU stay > 14 days. Least absolute shrinkage and selection operator (LASSO) regression was used to select risk factors, followed by multivariable logistic regression to identify independent predictors for CCI and PICS. Discriminative ability of early severity scores was assessed using the area under the curve (AUC) and compared via the DeLong’s test. Kaplan–Meier and Cox regression evaluated in-hospital and 90-day mortality differences. Results: Among 156 SAP patients, 60 (38.5%) developed CCI, 38 (24.4%) progressed to PICS, and 32 (20.5%) met both criteria. After multivariable adjustment and sensitivity analyses, the computed tomography severity index (CTSI) emerged as an independent risk factor for both CCI (odds ratio [OR]: 1.40, 95% confidence interval [CI] 1.18–1.66) and PICS (OR: 1.56, 95% CI 1.29–1.89), with AUC values of 0.747 and 0.804, respectively. Significant differences in both the in-hospital and 90-day mortality rates were observed among the three groups (p < 0.001). The patients meeting both CCI and PICS criteria exhibited markedly increased risks of in-hospital (hazard ratio [HR]: 7.80, 95% CI 1.53–39.77; p = 0.013) and 90-day mortality (HR: 3.11, 95% CI 1.08–8.95; p = 0.035) after the multivariable adjustment. Conclusions: CTSI is an independent risk factor for CCI and PICS in patients with SAP. Both CCI and PICS were associated with a heightened risk of adverse outcomes. Future studies are warranted to explore the clinical characteristics and targeted interventions for this high-risk subgroup.